Vasanthi Vara

XtalPi’s AI biologics discovery platform licensed to Janssen

The non-exclusive licence will enable Janssen to utilise Xtalpi’s proprietary AI biologics discovery platform. Credit: Premreuthai/Shutterstock. XtalPi, an AI drug discovery company and subsidiary of

Vasanthi Vara October 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Vasanthi Vara

XtalPi’s AI biologics discovery platform licensed to Janssen

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe